| Hang Seng Index | 25.360 HKD | -0.200 | -0.782% | 231.27M | 5.87B | 25.402 (-0.163%) HKD as at 2025/08/05 | | |
| Hang Seng China Enterprises | 91.120 HKD | -0.800 | -0.870% | 55.98M | 5.11B | 91.618 (-0.543%) HKD as at 2025/08/05 | | |
| Hang Seng TECH Index | 5.365 HKD | -0.080 | -1.469% | 607.16M | 3.27B | 5.425 (-1.099%) HKD as at 2025/08/05 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.355 HKD | -0.145 | -2.636% | 120.80M | 650.98M | 5.495 (-2.553%) HKD as at 2025/08/05 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.602 HKD | +0.038 | +2.430% | 213.32M | 339.89M | 1.567 (+2.207%) HKD as at 2025/08/05 | | |
| Hang Seng TECH Index | 11.510 HKD | -0.150 | -1.286% | 16.14M | 186.47M | 11.551 (-0.358%) HKD as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.610 HKD | -0.085 | -1.493% | 24.03M | 135.24M | 5.619 (-0.164%) HKD as at 2025/08/05 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.054 HKD | +0.030 | +1.482% | 59.74M | 122.40M | 2.054 (+0.019%) HKD as at 2025/08/05 | | |
| Hang Seng China Enterprises | 10.560 HKD | -0.050 | -0.471% | 10.52M | 111.23M | 10.502 (+0.548%) HKD as at 2025/08/04 | | |
| Hang Seng TECH Index | 5.455 HKD | -0.070 | -1.267% | 14.31M | 78.33M | 5.508 (-0.964%) HKD as at 2025/08/05 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 16.400 HKD | -0.240 | -1.442% | 2.66M | 43.53M | 17.004 (-3.553%) HKD as at 2025/08/05 | | |
| London Gold Fixing Price | 2,451.000 HKD | -4.000 | -0.163% | 15.66K | 38.39M | N/A | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.880 HKD | +0.270 | +1.533% | 1.38M | 24.72M | 17.206 (+3.920%) HKD as at 2025/08/04 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 9.395 HKD | +0.510 | +5.740% | 1.80M | 16.93M | 8.717 (+7.784%) HKD as at 2025/08/05 | | |
| Hang Seng High Dividend Yield | 30.320 HKD | 0.000 | 0.000% | 417.80K | 12.66M | 29.520 (+2.711%) HKD as at 2025/08/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.794 HKD | -0.008 | -0.210% | 3.23M | 12.25M | 3.876 (-2.103%) HKD as at 2025/08/04 | | |
| CSI 300 | 46.420 HKD | +0.020 | +0.043% | 238.39K | 11.08M | 46.365 (+0.119%) HKD as at 2025/08/05 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 49.840 HKD | -2.300 | -4.411% | 166.46K | 8.28M | 52.783 (-5.575%) HKD as at 2025/08/05 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.450 HKD | +0.230 | +1.617% | 560.20K | 8.10M | 14.112 (+2.397%) HKD as at 2025/08/05 | | |
| FTSE China A50 | 13.840 HKD | -0.050 | -0.360% | 546.32K | 7.57M | 13.821 (+0.135%) HKD as at 2025/08/05 | | |
| CME Ether Futures | 18.540 HKD | +1.050 | +6.003% | 335.60K | 6.20M | 17.388 (+6.628%) HKD as at 2025/08/04 | | |
| Solactive China Healthcare Disruption Index | 3.738 HKD | -0.002 | -0.053% | 1.64M | 6.14M | 3.867 (-3.323%) HKD as at 2025/08/05 | | |
| FTSE US Treasury 20+ Years Index | 68.640 HKD | -0.200 | -0.291% | 89.17K | 6.13M | 69.045 (-0.587%) HKD as at 2025/08/04 | | |
| London Gold Fixing Price | 80.400 HKD | -0.060 | -0.075% | 75.31K | 6.06M | 79.745 (+0.821%) HKD as at 2025/08/05 | | |
| Hang Seng Index | 23.200 CNY | -0.160 | -0.685% | 219.50K | 5.09M | 23.272 (-0.310%) CNY as at 2025/08/05 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.418 HKD | -0.072 | -2.063% | 1.46M | 4.99M | 3.452 (-0.979%) HKD as at 2025/08/05 | | |
| FTSE China A50 | 14.870 HKD | -0.030 | -0.201% | 324.16K | 4.82M | 14.709 (+1.098%) HKD as at 2025/08/04 | | |
| CME Bitcoin Futures | 39.500 HKD | +0.660 | +1.699% | 117.95K | 4.67M | 38.853 (+1.667%) HKD as at 2025/08/04 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.618 HKD | +0.028 | +0.780% | 1.16M | 4.20M | 3.616 (+0.047%) HKD as at 2025/08/05 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 9.455 HKD | +0.500 | +5.583% | 421.60K | 3.98M | 8.801 (+7.436%) HKD as at 2025/08/05 | | |